Cannon, M.; Phillips, H.; Smith, S.; Williams, K.; Brinton, L.; Gregory, C.; Landes, K.; Desai, P.; Byrd, J.; Lapalombella, R.
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease. J. Clin. Med. 2020, 9, 2276.
https://doi.org/10.3390/jcm9072276
AMA Style
Cannon M, Phillips H, Smith S, Williams K, Brinton L, Gregory C, Landes K, Desai P, Byrd J, Lapalombella R.
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease. Journal of Clinical Medicine. 2020; 9(7):2276.
https://doi.org/10.3390/jcm9072276
Chicago/Turabian Style
Cannon, Matthew, Hannah Phillips, Sidney Smith, Katie Williams, Lindsey Brinton, Charles Gregory, Kristina Landes, Payal Desai, John Byrd, and Rosa Lapalombella.
2020. "Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease" Journal of Clinical Medicine 9, no. 7: 2276.
https://doi.org/10.3390/jcm9072276
APA Style
Cannon, M., Phillips, H., Smith, S., Williams, K., Brinton, L., Gregory, C., Landes, K., Desai, P., Byrd, J., & Lapalombella, R.
(2020). Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease. Journal of Clinical Medicine, 9(7), 2276.
https://doi.org/10.3390/jcm9072276